(Webinar held: October 27, 2020) Join HDA and The Hill for a virtual conversation between policymakers, health officials and healthcare stakeholders on ensuring resilience in the pharmaceutical supply chain — whether in the face of COVID-19 or future health crises.
The global pandemic has led to an unprecedented demand for medicines. What are stakeholders doing to ensure that disruptions do not occur, especially as we head into flu season and colder weather? How can all those involved in maintaining an uninterrupted supply of pharmaceuticals collaborate effectively across the supply chain and with government officials? And what plans are being put in place for the distribution of a coronavirus vaccine once available?
This event is headlined by former HHS Secretary Kathleen Sebelius; former FDA Commissioner and Resident Fellow, American Enterprise Institute, Dr. Scott Gottlieb; Rep. Buddy Carter (R-Ga.), Member, Energy and Commerce Committee; and Rep. Elissa Slotkin (D-Mich.), Sponsor, Made in America Medical Supply Chain Initiative. The program also features a conversation between HDA President and CEO Chip Davis and The Hill’s Editor-at-Large Steve Clemons.
The event concludes with additional perspectives from: